Xin Gu Selected Research

Enzymes

1/2017	Antagomirs Targeting MiroRNA-134 Attenuates Epilepsy in Rats through Regulation of Oxidative Stress, Mitochondrial Functions and Autophagy.
3/2013	SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression.
3/2011	Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.
1/2009	Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Gu Research Topics

Disease

51	Neoplasms (Cancer) 04/2024 - 12/2003
11	Breast Neoplasms (Breast Cancer) 09/2023 - 06/2005
10	Inflammation (Inflammations) 05/2024 - 01/2009
10	Carcinogenesis 11/2022 - 08/2005
9	Syphilis 05/2024 - 11/2010
7	Infections 12/2023 - 11/2008
7	Fibrosis (Cirrhosis) 09/2023 - 09/2015
7	Intervertebral Disc Displacement (Herniated Disc) 10/2022 - 01/2016
6	Neurosyphilis (General Paresis of the Insane) 04/2024 - 08/2012
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022 - 06/2005
5	Pain (Aches) 01/2024 - 10/2011
5	Renal Cell Carcinoma (Grawitz Tumor) 09/2022 - 10/2013
4	Pathologic Processes 07/2023 - 01/2020
4	Body Weight (Weight, Body) 05/2023 - 01/2009
4	Epilepsy (Aura) 01/2023 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 01/2020
4	Hyperplasia 11/2022 - 01/2009
4	Erectile Dysfunction 03/2022 - 01/2019
4	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 11/2010
4	Starvation 01/2022 - 11/2017
4	secondary Syphilis 11/2021 - 11/2010
3	Ischemic Stroke 04/2024 - 01/2022
3	Myocardial Infarction 11/2023 - 01/2018
3	Lung Neoplasms (Lung Cancer) 05/2023 - 12/2019
3	Hypertrophy 01/2023 - 09/2015
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 01/2020
3	Heart Failure 01/2022 - 01/2020
3	primary Syphilis 11/2021 - 11/2010
3	Hypoxia (Hypoxemia) 01/2021 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 03/2012
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 01/2017
2	Arthritis (Polyarthritis) 12/2023 - 10/2016
2	Wounds and Injuries (Trauma) 11/2023 - 03/2015
2	Lymphoma (Lymphomas) 09/2023 - 10/2016
2	Pre-Eclampsia (Preeclampsia) 01/2023 - 10/2009
2	Obesity 01/2023 - 01/2015
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 11/2018
2	Hemorrhage 09/2022 - 12/2011
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Latent Syphilis 11/2021 - 05/2018
2	Postoperative Pain 08/2021 - 05/2018
2	Carcinoid Tumor (Carcinoid) 03/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2005
6	Messenger RNA (mRNA)IBA 05/2023 - 07/2010
5	LigandsIBA 04/2024 - 01/2017
5	InflammasomesIBA 09/2023 - 01/2018
5	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 09/2016
5	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 04/2016
5	Galectin 3 (LGALS3)IBA 01/2021 - 10/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 10/2009
4	Circular RNAIBA 04/2024 - 01/2020
4	CytokinesIBA 12/2023 - 01/2021
4	Therapeutic UsesIBA 09/2023 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2011
4	CeramidesIBA 01/2020 - 03/2011
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 04/2013
4	MicroRNAs (MicroRNA)IBA 01/2019 - 02/2014
4	EnzymesIBA 01/2017 - 01/2009
4	ceramide glucosyltransferaseIBA 09/2016 - 03/2011
3	LipopolysaccharidesIBA 05/2024 - 10/2016
3	Peptides (Polypeptides)IBA 04/2024 - 01/2022
3	CollagenIBA 01/2024 - 09/2015
3	musconeIBA 11/2023 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 09/2023 - 01/2022
3	Adenosine Triphosphate (ATP)IBA 01/2023 - 06/2015
3	Formaldehyde (Formol)FDA Link 01/2023 - 03/2015
3	AZD4547IBA 11/2022 - 04/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 03/2012
3	Small Interfering RNA (siRNA)IBA 01/2020 - 03/2012
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2017
3	ReaginsIBA 03/2014 - 11/2010
2	Penicillins (Penicillin)FDA Link 05/2024 - 02/2015
2	Nucleic AcidsIBA 04/2024 - 07/2020
2	UbiquitinIBA 12/2023 - 02/2014
2	Histones (Histone)IBA 12/2023 - 09/2023
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2023 - 01/2022
2	PeptidomimeticsIBA 05/2023 - 01/2022
2	AntioxidantsIBA 05/2023 - 01/2009
2	IntegrinsIBA 01/2023 - 01/2022
2	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2022
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2022 - 10/2019
2	Leucine (L-Leucine)FDA Link 01/2022 - 12/2019
2	InterferonsIBA 01/2022 - 07/2014
2	Treponema pallidum 47-kDa immunogenIBA 11/2021 - 05/2018
2	Indicators and Reagents (Reagents)IBA 11/2021 - 08/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2021 - 07/2010
2	LuciferasesIBA 01/2021 - 12/2019
2	Hypoxia-Inducible Factor 1IBA 01/2021 - 12/2018
2	SteroidsIBA 01/2021 - 05/2018

Therapy/Procedure

14	Therapeutics 04/2024 - 06/2005
11	Diskectomy (Discectomy) 01/2024 - 01/2016
6	Drug Therapy (Chemotherapy) 09/2023 - 07/2010
4	Aftercare (After-Treatment) 11/2021 - 11/2010
3	Length of Stay 09/2022 - 12/2011
3	Decompression 10/2021 - 12/2011
3	Chemoprevention 01/2018 - 01/2009
2	Operative Time 11/2023 - 08/2021
2	Foraminotomy 11/2022 - 01/2021
2	Nephrectomy 03/2021 - 11/2016